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Abstract: Dirofilaria immitis (D. immitis); is a parasitic zoonosis with a prevalence of 53.8%, whose intermediate host is mosquitoes
(Anopheles, Aedes, Culex, Taeniorhychus, Mansonia and Armigenes), final hosts are carnivores (dog, cat, fox, etc.) and humans. The
causative agent settles in the pulmonary arteries and causes pulmonary hypertension, which can progress to congestive heart failure.
Cardiac troponins (cTn), which have recently been used in veterinary cardiology, are considered the gold standard because of their high
sensitivity and specificity for myocardial injury. In the study, high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity cardiac
troponin I (hs-cTnI) levels in healthy dogs were determined as 0.092 ± 0.009 and 0.135 ± 0.024 ng/mL, respectively. In dogs with D.
immitis, hs-cTnT and hs-cTnI levels in healthy dogs were determined as 0.164 ± 0.035 and 0.234 ± 0.052, respectively. As a result; it was
determined that there was an increase in hs-cTnT and hs-cTnI levels in dogs with D. immitis, although it was not statistically significant
(p > 0.05). Considering that even the slightest change in the levels of troponins is prognostically important, it can be said that D. immitis
causes myocardial damage in dogs.
Key words: Canine, Dirofilaria, Troponin, vector induced diseases

1. Introduction
Dirofilaria immitis (D. immitis); is a parasitic zoonosis
in the Filaroidea superfamily of the nematode class,
whose intermediate host is mosquitoes (Anopheles,
Aedes, Culex, Taeniorhychus, Mansonia and Armigenes)
the final host is carnivores (dog, cat, fox, etc.) and
humans [1,2]. Dirofilaria immitis, the prevalence of
which varies between 0.4%– 53.8% in the world [3–7] is
one of the most important vector-borne agents among
nematode species that infects dogs [8]. The agent
settles in the right atrium and ventricle of the heart,
pulmonary arteries, and camra oculi anterior in animals
and humans, causing pulmonary hypertension which
can progress to congestive heart failure characterized
by endarteritis, embolization, and thromboembolism
[9,10].
Cardiac troponins (cTn), which have recently
been used in veterinary cardiology are accepted as
the gold standard due to their high sensitivity and
specificity for myocardial damage [11–13]. Troponins
are globular proteins that have a role in the contraction

and relaxation of myofibrils [14] and they are included
in the circulation when cardiac myocytes are destroyed
[15]. It has been reported that cardiac troponin I
(cTn-I) and cardiac troponin T (cTn-T) are specific
for the heart and show a high sensitivity to myocardial
necrosis [16,17]. High-sensitivity cTn-T (hs-cTnT)
and high-sensitivity cTn-I (hs-cTnI) levels allow the
determination of lower levels compared to cTn-T
and cTn-I values, making it possible to detect mild
myocardial damage that may occur in the early stages
of diseases [18].
It has been reported that even small changes in the
levels of troponins, which are frequently used in human
studies, have prognostic significance [19–21]. For this
reason, more and more sensitive analyses have been
used in recent years [15]. In this study, it was aimed to
determine in the D. immitis, which is one of the vectorborne zoonotic diseases (VBZD), by measuring with high
sensitivity with the commercial Elisa kit of cTn-I, which
have just started to be used in the veterinary field, in dogs
according to age, sex and healthy ones.
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2. Materials and methods
2.1. Animal material
The material of the study consisted of 15 dogs diagnosed
with D. immitis and 15 healthy dogs which were brought
to Iğdır University Tuzluca Animal Hospital. Diagnosis
of D. immitis was made with the rapid diagnosis kit
(SensPERT® One Step Rapid Test Kit, VetAll Laboratories,
Korea). Five mL blood was collected from V. cephalica of
sick and healthy animals into serum tubes. After these
bloods were centrifuged at 3000 rpm for 10 min, their
serums were separated. The serums were stored at –20 °C
until the hs-cTnI levels were measured. Although troponin
concentrations can remain stable for a long time at –70/–
80 °C, it has been reported that they remain stable at –20
°C for a maximum of 3 months [15,22,23]. For this reason,
the serum samples used in the study are 60 days old.
2.2. Measurement of cardiac markers
Levels of serum hs-cTnT and hs-cTnI, were determined
by ELISA equipment (Thermo Scientific Multiscan GO,
TYPE: 1510) and calculated with commercial test kit (ng/
mL) as instructed by the manufacturer (Canine High
Sensitivity Cardiac Troponin T and I Kit, BT Lab, Korea).
2.3. Statistical analysis
SPSS 20 software was used for statistical analysis of the
obtained data. Independent t-test and General Linear
Model (GLM) procedure were followed to reveal the
differences in hs-cTnT and I levels of healthy dogs and the
dogs with D. immitis according to age and sex. The results
were given as mean ± SE and mean ± SD.
3. Results
The dogs participating in the study; 47% (14/30) were
females and 53% (16/30) were males. The changes in hscTnT and hs-cTnI in healthy dogs and dogs with D. immitis
are given in Table 1.
When Table 1 was examined, although hs-cTnT levels
were found to be 0.164 ± 0.136 ng/mL in dogs with D.
immitis and 0.092 ± 0.035 ng/mL in healthy dogs, no
statistically significant difference was found between the
groups in the analysis (T = 1.961, p > 0.05). Although hscTnI level was found to be 0.234 ± 0.200 ng/mL in dogs
with D. immitis and 0.135 ± 0.092 ng/mL in healthy dogs,
no statistically significant difference was found between
the groups in the analysis (T = 1.739, p > 0.05).
When Table 2 is examined, hs-cTnT and hs-cTnI levels
were determined to be 0.098 ± 0.051, 0.159 ± 0.089 ng/mL
in female dogs and 0.015 ± 0.132, 0.208 ± 0.206 ng/mL
in male dogs, respectively, and no statistically significant
difference was found between the groups in the analysis
performed (p > 0.05).
The dogs were included into the study; 60% were 4
years old an below, 40% were 5 years old and above, and

Table 1. The hs-cTnT and hs-cTnI changes in healthy dogs and
dogs with D. immitis.
Parameters

hs-cTnT
(ng/mL)

hs-cTnI
(ng/mL)

Group

N

Mean ± SE
(Min-max)

D.immitis

15

0.164 ± 0.035
(0.027–0.603)

15

0.092 ± 0.009
(0.021–0.160)

D.immitis 15

0.234 ± 0.052
(0.077–0.919)

Healthy

0.135 ± 0.024
(0.070–0.377)

Healthy

15

T/P

T = 1.961
p > 0.05

T= 1.739
p > 0.05

Table 2. The changes of hs-cTnT and hs-cTnI in dogs by sex.
Parameters

hs-cTnT
(ng/mL)

hs-cTnI
(ng/mL)

Sex

N

Mean ± SE
(Min–max)

Female

14

0.098 ± 0.014
(0.021–0.161)

Male

16

0.015 ± 0.033
(0.034–0.603)

Female

14

0.159 ± 0.024
(0.071–0.377)

16

0.208 ± 0.051
(0.076–0.919)

Male

T/P

T = 1.452
p > 0.05

T = 0.830
p > 0.05

there was no statistically significant difference between the
groups in the analysis (p > 0.05; Table 3).
General Linear Model (GLM) was applied to reveal the
effect of age, sex and presence of D. immitis on hs-cTnT
and hs-cTnI, and the data obtained are given in Table 4.
When Table 4 is examined, although hs-cTnT and hscTnI values in sick animals have a higher average than
healthy animals, it is seen that the interactive effects of
sex, age and D. immitis on hs-cTnT and hs-cTnI are not
statistically significant in the GLM analysis (p > 0.05).
4. Discussion
Vector-borne zoonotic diseases have importance
increasing day by day due to factors such as climate changes,
unconscious drug use, genetic changes in pathogens,
uncontrolled human and animal movements [24]. Among
the nematode species, one of the most important vectorborne agents infecting dogs is D. immitis [8]. The agent
causes pulmonary hypertension that can progress to
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Table 3. The changes of hs-cTnT and hs-cTnI according to age
in dogs.
Parameters

hs-cTnT
(ng/mL)

hs-cTnI
(ng/mL)

Age

N

Mean ± SE
(Min–max)

≤4

18

0.151 ± 0.029
(0.027–0.272)

≥5

12

0.093 ± 0.013
(0.021–0.176)

≤4

18

0.213 ± 0.045
(0.071–0.919)

≥5

12

0.141 ± 0.023
(0.077–0.186)

T/P

Table 4. The effect of age, sex, and presence of D. immitis on hscTnT and hs-cTnI according to the GLM procedure.
Parameters
Group

T = 1.515
p > 0.05

T = 1.209
p > 0.05

Sex
Female

D.immitis Male

Total

congestive heart failure [9,10]. In addition, worms that
die naturally or are killed as a result of treatment can
cause pulmonary thromboembolism, granulomatous
inflammation, arterial occlusion and vasoconstriction
[21].
Troponins are structural proteins that are a part of
the contractile apparatus of skeletal and cardiac muscle,
responsible for regulating the interaction of actin and
myosin, and are composed of three subunits called troponin
I (inhibitory component), troponin T (tropomyosin
binding) and troponin C (calcium binding) [15]. When
heart damage occurs, cTn-I and cTn-T begin to be secreted
within 3–8 h, reach the highest level in 6–12 h and remain
at a high level in blood for 14–21 days [12,25,26].
Cardiac troponin T has been reported to be a specific
biomarker of cardiac muscle and minimally secreted
in skeletal muscle [15,27,28]. In different studies, it has
been reported that the cTn-T level in healthy dogs ranges
from <0.01 to <0.05 ng/mL [29,30]. In the study, hs-cTnT
level, which was stated to be more sensitive than cTn-T
in different studies, was evaluated and hs-cTnT level was
determined as 0.092 ± 0.009 ng/mL in our control group.
The reason why the hs-cTnT level was numerically higher
than the cTn-T values mentioned

above is thought to be
due to the high sensitivity of the measurement. In addition,
it has been reported in different studies that cTn-T has
increased in cardiac injuries in dogs [31,32]. In two
different studies conducted on dogs with D. immitis, no
change was found in the cTn-T level [33,34]. In our study,
although the hs-cTnT levels were found to be 0.164 ± 0.136
ng/mL in dogs with D. immitis and 0.092 ± 0.035 ng/mL
in healthy dogs, no statistically significant difference was
found between the groups (p > 0.05).
In a study, it has been reported that cTn-I is more
specific than cTn-T [35]. The fact that the molecular weight
of cTn-I is lower has been demonstrated as the reason
for this [36]. Therefore, cTn-I is considered to be a more
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Female

Healthy

Male

Total
Total
Female

Male
Total

hs-cTnT

hs-cTnI

Age

Mean ± SD

Mean ± SD

≤4

0.104 ± 0.066

0.205 ± 0.052

≥5

0.121 ± 0.009

0.144 ± 0.059

Total

0.109 ± 0.055

0.187 ± 0.057

≤4

0.268 ± 0.194

0.353 ± 0.328

≥5

0.115 ± 0.070

0.144 ± 0.025

Total

0.211 ± 0.171

0.275 ± 0.271

≤4

0.186 ± 0.162

0.279 ± 0.235

≥5

0.118 ± 0.050

0.144 ± 0.034

Total

0.163 ± 0.136

0.234 ± 0.200

≤4

0.127 ± 0.020

0.086 ± 0.026

≥5

0.058b ± 0.041

0.161 ± 0.144

Total

0.088 ± 0.048

0.129 ± 0.110

≤4

0.094 ± 0.016

0.158 ± 0.100

a

≥5

0.097 ± 0.031

0.110 ± 0.034

Total

0.095 ± 0.020

0.140 ± 0.082

≤4

0.106 ± 0.023

0.131 ± 0.085

≥5

0.075 ± 0.040

0.139 ± 0.107

Total

0.092 ± 0,350

0.135 ± 0.093

≤4

0.113 ± 0.052

0.160 ± 0.074

≥5

0.079 ± 0.045

0.155 ± 0.115

Total

0.098 ± 0.051

0.158 ± 0.090

≤4

0.181 ± 0.159

0.256 ± 0.250

≥5

0.106 ± 0.050

0.127 ± 0.033

Total

0.153 ± 0.132

0.207 ± 0.206

≤4

0.151 ± 0.125

0.213 ± 0.195

≥5

0.093 ± 0.047

0.141 ± 0.082

Total

0.127 ± 0.104

0.184 ± 0.162

D. immitis*Sex

-p > 0.05

-p > 0.05

D. immitis*Age

-p > 0.05

-p > 0.05

D. immitis*Sex*Age

-p > 0.05

-p > 0.05

sensitive and specific marker than cTn-T for the detection
of minor myocardial damage [15,21]. In different studies,
it has been reported that the level of cTn-I in healthy dogs
varies between 0.004 and 0.136 ng/mL [37,38]. In our
study, in parallel with previous studies, hs-cTnI level in
healthy dogs was determined as 0.135 ± 0.024 ng/mL. In
different studies on dogs, it has been reported that cTn-I
levels increase in cardiac damage [39–45]. In the studies
on dogs with D. immitis, it has been also reported that
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cTn-I levels increase significantly [33,46]. In our study,
although the hs-cTnI level was found to be 0.234 ± 0.200
ng/mL in dogs with D. immitis and 0.135 ± 0.092 ng/mL
in healthy dogs, no statistically significant difference was
found between the groups (p > 0.05). The lack of statistical
significance among the groups may have resulted from the
low population size due to ethical scope.
In different studies on humans, it has been reported
that the level of cTn-I is higher in men [47–49]. However,
although hs-cTnT and hs-cTnI levels were higher in male
dogs in our study, no statistically significant difference was
found between the groups in the analysis (p > 0.05).
In a human study, slight increases in cTn-I levels were
reported due to increased myocardial reformation with
possible cardiomyocyte loss characterized by aging [50].
In a study conducted on dogs, it has been reported that
there is a significant correlation between age and cTn-I
level [39]. Although hs-cTnT and hs-cTnI levels were
higher in 4 ≥ dogs in our study, no statistically significant
difference was found between the groups in the analysis
performed (p > 0.05).
5. Conclusion
As a result, it was determined that there was an increase
in hs-cTnT and hs-cTnI levels in dogs with D. immitis,
although it was not statistically significant. Considering
that even the slightest change on the levels of troponins is
prognostically important [19,21,37], it can be said that D.
immitis causes myocardial damage in dogs. In addition, it

has been reported that cTn-I may not increase in the early
stages of heart damage in some patients [25,51].
It can be said that hs-cTnT and hs-cTnI levels will
increase as the prognosis of the disease worsens in dogs
infected with D. immitis. In this point, the lack of statistical
significance among the groups may have resulted from the
low population size due to ethical scope. Therefore, it is
thought that statistical differences may be significant if a
larger population study is reconstructed. In the literature
review on hs-cTnT and hs-cTnI levels in dogs, it was
observed that there were not enough studies/findings and
our study is the first data. In addition, considering different
age and sex groups in dogs, we think that investigating
different stages of D. immitis (early-mid-late period) by
evaluating more dogs will provide more comprehensive
data on this subject.
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